Kiniksa Pharmaceuticals International, plc - 8-K Filing

Kiniksa reports Q2 revenue of $243.6M from ARCALYST, raises full-year guidance to $980–$995M (Items: 2.02 Results of Operations and Financial ConditionOn July 28, 2026, Kiniksa Pharmaceuticals International, plc issued a press release announcing, 9.01 Financial Statements and Exhibits)

SEC EDGAR · July 28, 2026, 11:34 UTC

Tickers: $KNSA

Read the full article at SEC EDGAR

More Regulatory news

XBiotech Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 15:53 UTC
Cohen & Co Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 15:48 UTC
UNITED BANCORP INC /OH/ - 10-Q Filing SEC EDGAR · November 12, 2026, 15:33 UTC
PATRIOT GOLD CORP - 10-Q Filing SEC EDGAR · November 12, 2026, 15:32 UTC
First Digital Acquisition Corp Ltd. - 8-K Filing SEC EDGAR · November 12, 2026, 15:29 UTC
GROOVE BOTANICALS INC. - 10-Q Filing SEC EDGAR · November 12, 2026, 15:24 UTC
Johnson Controls International plc - 10-K Filing SEC EDGAR · November 12, 2026, 15:24 UTC
OLD NATIONAL BANCORP /IN/ - 8-K Filing SEC EDGAR · November 12, 2026, 15:20 UTC
AMTECH SYSTEMS INC - 8-K Filing SEC EDGAR · November 12, 2026, 15:16 UTC
REGIONAL HEALTH PROPERTIES, INC - 8-K Filing SEC EDGAR · November 12, 2026, 15:09 UTC